Evaluation of Clinical Results regarding Peristomal Skin Health Associated with the Adjustment and Formulation of the New Moderma Flex One-Piece Ostomy Devices
by
and
Sebastian Rivera García
1,
Esperanza-Macarena Espejo Lunar
1,
Julian Rodríguez-Almagro
2,* and
Silvia Louzao Méndez
3 1
Stomaterapeuta Nurse, University Hospital Virgen del Rocío de Sevilla, 41013 Seville, Spain
2
Faculty of Nursing, University of Castilla-La Mancha, 13001 Ciudad Real, Spain
3
University Hospital of A Coruña, 15006 A Coruña, Spain
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2023, 13(2), 219; https://doi.org/10.3390/jpm13020219
Submission received: 16 October 2022
/
Revised: 19 January 2023
/
Accepted: 20 January 2023
/
Published: 26 January 2023
Abstract
:In order to determine the perception of ostomized patients about the performance and safety of the new one-piece device Moderma Flex, as well as the evolution of peristomal skin health after its use. The pre- and post-experimental multicenter study after the use of the Moderma Flex one-piece ostomy device on 306 ostomized people from 68 hospitals in Spain. We used a self-made questionnaire on the usefulness of different parts of the device and the perception of peristomal skin improvement. The sample was composed of 54.6% (167) men and had an average age of 64.5 years (standard deviation = 15.43). The type of device most commonly used according to its opening was closed by 45.1% (138). In addition, for the type of barrier, the most frequently used is the flat one; 47.7% (146) and 38.9% (119) used a model of soft convexity. A total of 48% scored with the highest assessment in the perception of skin improvement. The percentage of patients with peristomal skin problems decreased from 35.9% at the first visit to less than 8% after the use of Moderma Flex. Further, 92.4% (257) had no skin problems, the most frequent being erythema. The use of the Moderma Flex device seems to be related to a reduction in peristomal skin complications and a perception of improvement.
1. Introduction
The performance of an ostomy consists of a surgical procedure in which a hollow organ is connected to the outside. The creation of an ostomy may be necessary temporarily or permanently for the treatment of certain diseases of the digestive and urinary systems [1]. When a person has an ostomy, they suffer a series of biological, functional, psychological, and social alterations that make it difficult for them to adapt to their environment and impact their quality of life [2,3,4]. In addition, with this alteration in the elimination of feces/urine, they have to face hygienic and dietary changes and the loss of their control over sphincters, which can affect their perception of their own image. Further, they may even have difficulties reintegrating into their work, sexual, and social lives [5,6,7,8]. The performance of an ostomy implies the need for the person to acquire new skills for self-care of his stoma, such as correctly removing the pouch without causing injuries, performing proper hygiene on the stoma, maintaining the integrity and good health of the peristomal skin, properly placing the suitable pouch, or disposing of the pouch’s residue. For this reason, the selection of the ostomy device to use according to the needs of each person is fundamental to its reincorporation into their daily lives. The ostomy devices should be safe and easy to handle, acting as a barrier and preventing direct contact of stool or urine with the skin, while being comfortable and discreet so they do not alter the lifestyle of the ostomized person. On the other hand, there are multiple potential complications that can result from the placement of an ostomy, with skin problems being the most frequent. These can occur in between 3.1% and 46% of patients, depending on the location of the stoma and the study consulted [9,10,11,12].
In this context, several studies have reported that the safety against leaks and the protection and care of peristomal skin are two fundamental factors of great concern for the ostomized patient [13,14]. It is especially important to make the correct adjustment of the barrier around the stoma for a proper seal. The solutions, such as soft convexity or the adhesive border built into the hydrocolloid barrier, are designed to provide better adjustment and fit around the stoma. In this way, the correct adaptation to the peristomal skin and the different abdominal contours could potentially prevent leakage and, consequently, the contact of aggressive effluents with the skin.
As a result of all these reasons, this study aims to determine the perception of ostomized patients about the performance and safety of the new one-piece device Moderma Flex® (Hollister, Madrid, Spain), widely used in other countries such as France and the United Kingdom [15,16], but recently incorporated in Spain, as well as the evolution of peristomal skin health after use.
2. Material and Methods
2.1. Design and Participants
This is a four-dimensional, pre-post, multicenter study on the use of the one-piece Moderma Flex ostomy device. This study was approved by the Ethics Committee in Clinical Research (CEIC) of the Virgen Macarena-Virgen del Rocio University Hospitals in Seville (Protocol Number MF-2021-03). We included elderly ostomized patients whose ostomy had been performed in a maximum of the last 12 months. Those patients who did not have sufficient cognitive capacity to participate in the study were excluded, as were patients with a colostomy, ileostomy, or urostomy whose temporality was less than six months, patients who required the use of firm or deep convexity, and those who did not agree to participate in the study. For the estimation of the sample size, the following parameters were considered for studies with paired measures: accepting an alpha risk of 0.05 and a beta risk of 0.2 in a bilateral contrast. A minimum of 251 subjects are required, assuming that the initial proportion of events is 14% (patients with peristomal cutaneous alterations prior to intervention [11]) and at the end, 7% (percentage of patients with peristomal cutaneous alterations after intervention). A 10 percent follow-up loss rate has been estimated.
2.2. Procedure for the Collection of Information
The study was carried out with the collaboration of nurses performing ostomy consultations in 68 centers of the network of Spanish hospitals. Each center recruited and followed a minimum of four patients. This recruitment was carried out during the hospital stay of newly operated patients and in outpatient consultations with patients with an existing ostomy. The nurses delivered the fact sheets to the patients, explained the study verbally, resolved doubts, and invited them to participate in this research.
They then completed a questionnaire on basic and clinical socio-demographic data. From then on, the researchers provided the Moderma Flex device (Hollister, Madrid, Spain) free of charge to patients who agreed to participate in the study. After 15 days of follow-up, a second consultation was held to obtain information on the clinical progress of the patient.
2.3. Information Sources and Study Variables
In the collection of the information, two questionnaires were used. The first questionnaire contained 13 questions, and the second questionnaire contained 9 questions. Questions 7, 8, and 9 were Likert-type (degree of agreement and utility valued from 1 to 5 points), where statements 11, 6, and 4 were grouped on the barrier, the urostomy device, and the display window, respectively. The first questionnaire collected information on sociodemographic and clinical variables such as the type of ostomy, morphology of the stoma, type of abdomen, temporality of the ostomy, skin type, peristomal skin problems, characteristics of the device used, frequency of change of device, and reason for change of the usual device. The second questionnaire collected information on the type of device used, accessories used, frequency of change, skin reaction to the adhesive edge, peristomal skin condition after use of the new device, functioning and performance of the skin barrier, urostomy device features, display window utility, and device safety by reporting adverse events. The questionnaire is available in the Supplementary Material.
2.4. Statistical Analysis Used
First, a descriptive analysis was performed using absolute and relative frequencies for qualitative variables and the mean with standard deviation for quantitative variables. Then, a bivariate analysis was performed on the improvement of peristomal skin based on device characteristics and time as ostomized, using the Student-Fisher t test and Variance Analysis (ANOVA), depending on the number of categories. A p value of 0.05 was considered significant. All analyses were performed with the SPSS v.24.0 statistical package.
3. Results
The study involved 306 patients in the first part and 294 in the second, after the use of the new Moderma Flex devices. Regarding the most important sociodemographic characteristics of the basic sample, 54.6% (167) were men and had an average age of 64.5 years (standard deviation = 15.43), with a minimum age of 31 and a maximum age of 92 years. As for the time since the ostomy was performed, the group that presented a higher frequency was those who had been between 1 month and 3 months, with 26.5% (81). The most frequent type of ostomy was a colostomy, with 57.3% (175), being permanent in 55.9% (171) and terminal in 69.9% (214). Among the characteristics of the abdomen of the patients, 52.6% presented a round morphology, and approximately 40–50% had a flaccid, globulose, or smooth abdomen. In terms of peristomal skin characteristics, only 4.6% (14) had an oily appearance, damaged 7.2% (22), and irritated 27.8% (85). Among the most frequently observed complications, irritative contact dermatitis occurred in 67 patients (21.9%), followed by mechanical dermatitis in 21 patients (6.9%), and granulomas in 10 patients (3.3%). Finally, only 9.2% presented a condition that posed a risk for peristomal skin, noting that 8 of the 28 patients with the condition were in treatment with chemotherapy (Table 1).
3.1. Description of the Device Used in the Initial Visit
The type of device most commonly used according to its opening is a closed 36.3% (111) and 51.0% (156) 2-device. Most used a flat barrier, 52.6% (161) of the cases. As for the accessories used, the belt stood out with 22.9% (70), followed by the hydrocolloid paste with 18.3% (56). On the other hand, they were also asked about the number of times they changed the device, to which they replied that 19.0% (58) changed it more than once a day and 20.9% every day (64). About the reason for change, 24.2% (74) reported leakage, and 9.8% reported irritation (30) (Table 2).
3.2. Description of the Moderma Flex Device Used
In the second part of the study, patients began using the one-piece Moderma Flex device with different options. The type of device most commonly used according to its opening was closed by 45.1% (138). As for the type of barrier, although the most frequently used is flat in 47.7% (146) of the cases, 38.9% (119) used a model of soft convexity. As complementary features, 40.1% (118) had an adhesive edge, and 55.4% (118) had a display window. As for the accessories used, the belt stood out with 25.2% (70), followed by hydrocolloid powder and barrier spray with 19.0% (56) and a hydrocolloid ring with 15.6% (46).
On the other hand, they were also asked about the number of times they changed the device. 40.1% (118) changed it more than once a day and 41.2% every day (121), while 16.7% (49) changed it every two days (Table 3).
3.3. Evaluation of Improvement, Adverse Events, Evaluation of the Barrier, Viewing Window, and Urostomy after the Use of the New Device
Among the key questions in the evaluation of the new device, they were asked about the degree of improvement of the peristomal skin, and 48% scored with the highest assessment (a lot), while only 6% scored with the most negative assessment (nothing). Regarding the complications observed, the low incidence of these is remarkable. Only 0.3% presented allergies, 2.4% irritation, and 2.7% itching. They were then asked about the function and performance of the barrier. In this sense, all items had an average agreement degree above 4.30 (the range of possible values was between 1 and 5), with the characteristics best valued being “the comfort of the barrier” and “the adaptation to the abdominal contour” with an average of 4.59, followed by “barrier flexibility” with an average of 4.48 (Table 4 and Figure 1).
Additionally, regarding the display window, almost all items had average scores above 4.40, highlighting “the possibility of inspecting the state of the stoma”, which stood at 4.72 on average (Figure 2). The group of urostomized patients was then asked about the functioning and performance of their device. The average scores were above 4.25 in all items (Table 4 and Figure 3). The presence of adverse skin events and their resolution were also evaluated. In this sense, 92.4% (257) presented no skin problem, and a total of 28 events were detected, the most frequent being erythema. That is, the percentage of patients with peristomal skin problems decreased from 35.9% in the first visit to a percentage lower than 8% after the use of Moderma Flex. After the end of the study, only 8 of the patients maintained the detected problem, which had not yet been solved (Table 5).
3.4. Subanalysis of Peristomal Skin Enhancement Depending on Device Characteristics and Ostomized Time
Finally, the perception of peristomal skin improvement was analyzed for all patients and for the subgroup of patients with damaged or irritated skin depending on the characteristics of the device. In this sense, only a statistically significant association was observed with the use of an adhesive border, both in all patients (p = 0.008) and in patients with damaged or irritated skin (p = 0.011). Specifically, those who do not use adhesive border presented higher average improvement scores than those who use it, although in both groups an improvement in the perception of peristomal skin was observed. No statistically significant differences were found in the rest of the comparisons (Table 6 and Table 7).
4. Discussion
This multicenter study was carried out in order to know the perception in the improvement of peristomal skin after the use of a new device for one-piece ostomies (Moderma Flex). The patients reported a positive assessment of the improvement of periostomal skin both in those who had it previously intact and without lesions, and in those who had it damaged, coinciding with the results of another previous study [17]. In the same vein, patients’ assessments of the characteristics of the barrier and the viewing window, as well as of the urostomy device, were very positive. No statistical differences were found with the main comparison variables, except for the use of the adhesive border. Specifically, the perception of improved peristomal skin was greater in those who did not use it. This result is perfectly logical and is explained because those patients who require the use of a pouch with an adhesive border are those who present leaks, making the a peristomal skin more damaged [18] and with greater difficulty for its improvement. However, both groups showed an improvement in the perception of peristomal skin. Moreover, the fact that there are no differences in perception according to the rest of the characteristics of the device (type of barrier, type of opening, window) could be attributed to the fact that the devices used have been selected according to the individual needs of each ostomate.
In addition, the percentage of patients with peristomal skin problems has fallen considerably from 35.9% in the first visit to less than 8% after the use of Moderma Flex. These results are very positive and are among those described by other studies. Specifically, Malik et al. [11] in a systematic review of clinical trials found an incidence of skin problems of 14.0% with a confidence interval between 2.4% and 46.2%, higher than the findings of this study. The main limitations of the study include the quasi-experimental design where there is no parallel control group, so some of the improvement could be attributed to the Hawthorne effect [19] and a short follow-up of patients, although the perception of improvement is likely to increase over time. In addition, it would have been advisable to have blinded the device used, although from a practical point of view, it would have been very complex since it is the patients themselves who perform the care of their ostomy and change of device. Otra limitación importante es que los pacientes son muy heterogeneous en cuanto a características clínicas, por lo que no se puede atribuir toda la mejora exclusivamente al empleo del dispositivo. In terms of strengths, the participation in the study of 68 centers stands out, presenting adequate external validity to be included in this sample of people from different geographical areas, health services, and adequate representation of ostomized patients.
Therefore, we can conclude that the use of the Moderma Flex device seems to be related to a reduction of peristomal skin complications and a perception of improvement. However, a longer-term follow-up would be advisable to determine the evolution of peristomal skin health, the quality of life of patients, and the incidence of other adverse events.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jpm13020219/s1.
Author Contributions
S.R.G. supervised and conducted meetings with patients and their evaluations; E.-M.E.L., data analysis and interpretation; S.L.M., statistical analysis and was blinded for the outcome assessment and measurements; S.R.G., study conception and design and data assembly; J.R.-A., manuscript writing. All authors have read and agreed to the published version of the manuscript.
Funding
The researchers did not receive any compensation for the development of the study. The costs of using these devices were financed by the Hollister company. However, once the study is finished, the expenses derived from the use of devices are totally or partially financed by the public health system or private health insurance, depending on each patient.
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee in Clinical Research (CEIC) of the Virgen Macarena-Virgen del Rocio University Hospitals in Seville (Protocol Number MF-2021-03).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Acknowledgments
Our thanks to all patients who volunteered for the study as well as to the nurses listed below, who participated in their recruitment and diligently responded to both questionnaires (pre and post Moderma Flex device use): Abilleira Torres, M.F., Abril Pontones, A.M., Agudo Arcos, M.C., Alcántara Moreno, C., Arcusa Mesa, S., Arrontes Caballero, G., Bombardó Soria, M., Bona Sánchez, M., Campos Guerra, I.M., Castaño Prieto, M.C., Castillo Millán, M., Cereijo Martínez, S., Chacón del Pino, E., Clemente Esteban, E., Coca López, M., Costa Quintas, R., de la Antonia Montoro, M., del Pino Zurita, C., Diarte Abenia, M.C., Estruch Peiró, M.D., Fabeiro Mouriño, M.J., Fernández González, M.M., Fernández Simón, A., Fiol Llamas, O., García López, C., Gil Molano, A., Goirizelaya Induráin, A., Gómez de la Luz, M., Gómez Garrote, M., González Gutierrez, R., González Mengual, S., Hernández Ferrándiz, M.C., Hervás García, M.L., García Hornero, E., Jurado Millán, L., Lacasa Moreno, E., Lado del Teso, A., Lara Sánchez, H., Lastra García, M.F., Lázaro Moncada, M., López Callejón, V.A., Louzao Méndez, S., Martín Romero, A.M., Martínez Llodra, M., Martínez Ortuño, F.J., Medina Méndez, M.M., Morales Ventura, E., Moreno de la Hidalga, M.A., Naranjo Peña, I., Oeo Delgado, B., Ordoñez Vazquez, M.T., Ortega Pérez, Y., Oto Puyuelo, I., Pardo Roda, P., Ruiz Espinosa, A.I., Peláez Álvarez, N., Pérez Lorenzo, N., Pérez Salazar, I., Pérez Sola, M.A., Petri Etxeberría, M., Ramos Morán, V., Ribas Esteva, M.G., Rodón Torrent, A., Romero Moreno, J., Royo Tolosana, P., Rubio Vázquez, M., Sabaté Aguila, I., Saiz Alegre, L., Sanfelix Vivó, C., San José Vergara, C., Sanz Ros, M.T., Sas Olivares, G., Serra Sastre, G., Sobrino Briones, M., Terrasa Lozano, B., Torres Cobos, S., Urios Valero, P., Vela Morales, O. and Vidal Morral, C.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Doughty, D. Principles of ostomy management in the oncology patient. J. Support. Oncol. 2005, 3, 59–69. Available online: https://pubmed.ncbi.nlm.nih.gov/15724947/ (accessed on 28 June 2022). [PubMed]
- Charúa-Guindic, L.; Benavides-León, C.; Villanueva-Herrero, J.; Jiménez-Bobadilla, B.; Abdo-Francis, J.; Hernández-Labra, E. Quality of life in ostomized patients. Cir. Cir. 2011, 59, 149–155. Available online: https://pubmed.ncbi.nlm.nih.gov/21631976/ (accessed on 28 June 2022).
- Neuberger, L.; Braude, P.; Weeks, K.; Braude, P.; Halliday, R.; McCarthy, K.; Carter, B. A new stoma for an older person—An association with quality of life and physical function: A systematic review. J. Am. Geriatr. Soc. 2022, 70, 2415–2425. [Google Scholar] [CrossRef] [PubMed]
- Kristensen, H.; Thyø, A.; Christensen, P. Systematic review of the impact of demographic and socioeconomic factors on quality of life in ostomized colorectal cancer survivors. Acta Oncol. 2019, 58, 566–572. [Google Scholar] [CrossRef] [PubMed]
- Albaugh, J.A.; Tenfelde, S.; Hayden, D.M. Sexual Dysfunction and Intimacy for Ostomates. Clin. Colon Rectal Surg. 2017, 30, 201–206. Available online: http://www.ncbi.nlm.nih.gov/pubmed/28684938 (accessed on 30 June 2022). [PubMed]
- Danielsen, A.K.; Burcharth, J.; Rosenberg, J. Spouses of patients with a stoma lack information and support and are restricted in their social and sexual life: A systematic review. Int. J. Colorectal Dis. 2013, 28, 1603–1612. [Google Scholar] [CrossRef] [PubMed]
- Tripaldi, C. Sexual function after stoma formation in women with colorectal cancer. Br. J. Nurs. 2019, 28, S4–S15. [Google Scholar] [CrossRef] [PubMed]
- Ayaz-Alkaya, S. Overview of psychosocial problems in individuals with stoma: A review of literature. Int. Wound J. 2019, 16, 243–249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maglio, A.; Malvone, A.P.; Scaduto, V.; Brambilla, D.; Denti, F.C. The frequency of early stomal, peristomal and skin complications. Br. J. Nurs. 2021, 30, 1272–1276. [Google Scholar] [CrossRef] [PubMed]
- Lindholm, E.; Persson, E.; Carlsson, E.; Hallén, A.M.; Fingren, J.; Berndtsson, I. Ostomy-related complications after emergent abdominal surgery a 2-year follow-up study. J. Wound Ostomy Cont. Nurs. 2013, 40, 603–610. [Google Scholar] [CrossRef] [PubMed]
- Malik, T.A.M.; Lee, M.J.; Harikrishnan, A.B. The incidence of stoma related morbidity—A systematic review of randomised controlled trials. Ann. R. Coll. Surg. Engl. R. Coll. Surg. Engl. 2018, 100, 501–508. [Google Scholar] [CrossRef] [PubMed]
- Steinhagen, E.; Colwell, J.; Cannon, L.M. Intestinal Stomas-Postoperative Stoma Care and Peristomal Skin Complications. Clin. Colon Rectal Surg. 2017, 30, 184–192. Available online: http://www.ncbi.nlm.nih.gov/pubmed/28684936 (accessed on 30 June 2022). [CrossRef] [PubMed]
- Berg, K.; Seidler, H. Randomized crossover comparison of adhesively coupled colostomy pouching systems. Ostomy Wound Manag. 2005, 51, 36. Available online: https://pubmed.ncbi.nlm.nih.gov/15984397/ (accessed on 28 June 2022).
- Marquis, P.; Marrel, A.; Jambon, B. Quality of life in patients with stomas: The Montreux Study. Ostomy Wound Manag. 2003, 49, 48–55. [Google Scholar]
- Malbos, N.; Ruelle, M.O.; Bodenez, C. Les stomies digestives et leur appareillage. Actual. Pharm. 2022, 61, 18–25. [Google Scholar] [CrossRef]
- Palmer, S.J. Overview of stoma care for community nurses. Br. J. Commun. Nurs. 2020, 25, 340–344. [Google Scholar] [CrossRef] [PubMed]
- Mora Rivas, C. Estudio Avance de los dispositivos de ostomía de una y dos piezas: Moderma flex y Conform 2 de Hollister. Metas Enferm. 2012, 14, 22–26. [Google Scholar]
- Hayles, K. Getting it right the first time: How to select stoma accessories. Gastrointest. Nurs. 2014, 12, 36–46. [Google Scholar] [CrossRef]
- Gachabayov, M.; Dyatlov, A.; Bergamaschi, R. Hawthorne Effect Should Be Controlled for in Quality Control Studies. JAMA Surg. Am. Med. Assoc. 2019, 154, 977. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
Distribution of scores in the evaluation of the usefulness of the barrier.
Figure 2.
Distribution of scores in the utility rating of the display window.
Figure 3.
Distribution of scores in evaluating the usefulness of the urostomy device.
Table 1.
Clinical and sociodemographic characteristics of study subjects.
| Clinical and Sociodemographic Characteristics | % (n) |
|---|---|
| Gender | |
| Man | 54.6 (167) |
| Woman | 45.4 (139) |
| Age (Years) | 64.5 (12.43) |
| Time from completion of ostomy | |
| <1 week | 8.8 (27) |
| 1 week–1 month | 22.5 (69) |
| 1 month–3 months | 26.5 (81) |
| 3 months–6 months | 19.3 (59) |
| 6 months–12 months | 22.9 (70) |
| Type of ostomy (depending on surgery) | |
| Urostomy | 17.6 (54) |
| Ileostmy | 25.2 (77) |
| Colostomy | 57.2 (175) |
| Type of ostomy according to duration | |
| Temporary | 44.1 (135) |
| Permanent | 55.9 (171) |
| Type of ostomy according to technique | |
| Loop ostomy | 20.6 (63) |
| Termina | 69.9 (214) |
| Other Type | 9.5 (29) |
| Morphology of the stoma | |
| Round | 52.6 (161) |
| Protruding | 32.0 (98) |
| Oval | 27.1 (83) |
| Flat | 29.1 (89) |
| Irregular | 6.9 (21) |
| Invaginate | 8.2 (25) |
| Edematous | 0.7 (2) |
| Stenosed | 1.3 (4) |
| Type of abdomen | |
| Smooth | 48.4 (148) |
| Globulous | 42.2 (129) |
| Folds | 32.0 (98) |
| Flaccid | 40.8 (125) |
| Scars | 26.1 (80) |
| Skin Type | |
| Dry | 40.5 (124) |
| Mixed | 54.9 (168) |
| Oily | 4.6 (14) |
| Skin type according to integrity | |
| Intact | 65.0 (199) |
| Irritated | 27.8 (85) |
| Damaged | 7.2 (22) |
| Complications observed in the skin | |
| None | 64.1 (196) |
| Irritative contact dermatitis | 21.9 (67) |
| Mechanical dermatitis | 6.9 (21) |
| Granuloma | 3.3 (10) |
| Pressure ulcer | 0.3 (1) |
| Dehiscence mucocutaneous suture | 2.3 (7) |
| Dermatitis Incrustation | 0.3 (1) |
| Incrustation | 0.3 (1) |
| Neoplasia | 0.3 (1) |
| You have a condition that can put peristomal health at risk | |
| No | 90.8 (278) |
| Yes | 9.2 (28) |
| Oncological treatment | 8 |
| Crohn desease | 2 |
| Paraestomal Hernia | 2 |
| Ulcerative colitis | 1 |
| Atopy/eczema/psoriasis | 3 |
Table 2.
Characteristics of the device used in the initial visit.
| Characteristics of the Device Used | % (n) |
|---|---|
| Type of device you currently use (opening) | |
| Closed | 36.3 (111) |
| Drainable | 25.2 (77) |
| With valve | 14.7 (45) |
| Does not apply | 23.8 (73) |
| Device currently in use (by pieces) | |
| 1 piece | 25.2 (77) |
| 2 pieces | 51.0 (156) |
| 3 pieces | 1.6 (5) |
| Others | 0.7 (2) |
| Does not apply | 21.6 (66) |
| Device currently used according to foil type | |
| Flat barrier | 52.6 (161) |
| Convex barrier | 23.2 (71) |
| Does not apply | 24.2 (74) |
| Accessories used with the device | |
| Hydrocolloid rings | 17.0 (52) |
| Hydrocolloid powders | 17.6 (54) |
| Protective strips | 2.0 (6) |
| Hydrocolloid paste | 18.3 (56) |
| Barrier cream | 0.0 (0) |
| Convex ring | 3.6 (11) |
| Belt | 22.9 (70) |
| Skin barrier spray | 17.0 (52) |
| Adhesive remover spray | 12.4 (38) |
| Other accessories | 17.0 (52) |
| Does not apply | 26.1 (80) |
| Number of accessories used | |
| None | 42.8 (131) |
| One | 22.2 (68) |
| Two | 20.9 (64) |
| Three | 11.1 (34) |
| Four | 1.6 (5) |
| Five | 1.0 (3) |
| Six | 0.3 (1) |
| Frequency of the device change | |
| More than once a day | 19.0 (58) |
| Every day | 20.9 (64) |
| Every two days | 21.9 (67) |
| Every three days | 16.0 (49) |
| Every four days | 2.6 (8) |
| Does not apply | 19.6 (60) |
| Reason for the device change | |
| Rutine | 50.3 (154) |
| Leaks | 24.2 (74) |
| Irritation | 9.8 (30) |
| Itching | 5.2 (16) |
| Peeling Sheet | 9.2 (28) |
| Erosion Sheet | 2.0 (6) |
Table 3.
Characteristics of the Moderma Flex device evaluated.
| Characteristics of the Device Used | % (n) |
|---|---|
| Type of device you currently use (opening) | |
| Closed | 45.1 (138) |
| Drainable | 34.0 (104) |
| With valve | 17.0 (52) |
| Missing | 12 |
| Device currently used (per sheet) | |
| Flat barrier | 47.7 (146) |
| Soft convex barrier | 38.9 (119) |
| Moderate convex barrier | 9.5 (29) |
| Missing | 12 |
| Adhesive border | |
| No | 59.9 (176) |
| Yes | 40.1 (118) |
| Missing | 12 |
| Viewing window | |
| No | 44.6 (131) |
| Yes | 55.4 (163) |
| Missing | 12 |
| Accessories used with the device | |
| Hydrocolloid rings | 15.6 (46) |
| Hydrocolloid powders | 19.0 (56) |
| Protective strips | 1.7 (5) |
| Hydrocolloid paste | 11.2 (33) |
| Barrier cream | 1.0 (3) |
| Convex rings | 4.1 (12) |
| Belt | 25.2 (74) |
| Skin barrier spray | 19.0 (56) |
| Adhesive remover spray | 17.0 (50) |
| Other accessories | 37.4 (110) |
| Number of accessories used | |
| None | 38.1 (112) |
| One | 28.6 (84) |
| Two | 20.4 (60) |
| Three | 8.2 (24) |
| Four | 4.1 (12) |
| Five | 0.3 (1) |
| Six | 0.3 (1) |
| Frequency of the device change | |
| More than once a day | 40.1 (118) |
| Every day | 41.2 (121) |
| Every two days | 16.7 (49) |
| Every three days | 1.7 (5) |
| Every four days | 0.3 (1) |
| Missing | 12 |
Table 4.
Evaluation of the improvement, adverse events, and foil and display window after the use of the device.
Table 4.
Evaluation of the improvement, adverse events, and foil and display window after the use of the device.
| Degree of Agreement (Scale 1 Nothing According to 5 Very Agree) | ||||||
|---|---|---|---|---|---|---|
| Nothing 1 n (%) | Little 2 n (%) | Indifferent 3 n (%) | Fairly 4 n (%) | Very 5 n (%) | Average (DE) | |
| Improvement of the periostomal skin | ||||||
| All (n = 294) | 18 (6.1) | 4 (1.4) | 43 (14.6) | 88 (29.9) | 141 (48.8) | 4.12 (1.11) |
| With intact skin (n = 190) | 15 (7.9) | 2 (1.1) | 28 (14.7) | 55 (28.9) | 90 (47.4) | 4.07 (1.17) |
| With damaged or irritated skin (n = 104) | 3 (2.9) | 2 (1.9) | 15 (14.4) | 33 (31.7) | 51 (49.0) | 4.22 (0.97) |
| Cutaneous lamina (n = 294) | ||||||
| Flexibility of the skin barrier | 1 (0.3) | 2 (0.7) | 17 (5.8) | 109 (37.1) | 165 (56.1) | 4.48 (0.67) |
| Adaptation to the peristomal area | 1 (0.3) | 3 (1.0) | 16 (5.4) | 94 (32.0) | 180 (61.2) | 4.45 (0.68) |
| Adaptation to the abdominal contour | 0 (0.0) | 2 (0.7) | 15 (4.9) | 84 (27.5) | 191 (62.4) | 4.59 (0.62) |
| Peristomal sealing of the barrier | 3 (1.0) | 4 (1.4) | 26 (8.5) | 103 (35.3) | 156 (53.4) | 4.39 (0.79) |
| Adhesion of the blade | 4 (1.4) | 2 (0.7) | 15 (5.1) | 89 (30.3) | 184 (62.6) | 4.52 (0.75) |
| Resistance to effluent erosion | 4 (1.4) | 4 (1.4) | 27 (9.2) | 107 (36.4) | 154 (52.4) | 4.38 (0.77) |
| Easy application of the barrier | 1 (0.3) | 2 (0.7) | 19 (6.5) | 88 (30.1) | 182 (62.3) | 4.53 (0.68) |
| Smoothness in the removal of the barrier | 2 (0.7) | 8 (2.7) | 31 (10.6) | 109 (37.2) | 143 (48.8) | 4.31 (0.82) |
| Blade comfort | 0 (0.0) | 2 (1.0) | 11 (3.7) | 91 (31.0) | 189 (64.3) | 4.59 (0.62) |
| Barrier safety | 6 (2.0) | 4 (1.4) | 21 (7.1) | 89 (30.3) | 174 (59.2) | 4.43 (0.85) |
| Overall performance of the sheet | 1 (0.3) | 10 (3.4) | 12 (4.1) | 106 (34.6) | 164 (56.0) | 4.44 (0.76) |
| Viewing option (n = 186) | ||||||
| Facilitate the placement of the barrier | 0 (0.0) | 3 (1.6) | 10 (5.4) | 32 (17.2) | 141 (75.8) | 4.67 (0.65) |
| Inspect the condition of the stoma | 0 (0.0) | 1 (0.5) | 9 (4.8) | 32 (17.2) | 146 (77.7) | 4.72 (0.58) |
| Inspect the effluent contained in the pouch | 2 (1.1) | 6 (3.2) | 15 (8.0) | 45 (24.1) | 119 (63.6) | 4.46 (0.86) |
| Provide greater discretion | 3 (1.6) | 1 (0.5) | 11 (5.9) | 29 (15.5) | 143 (76.5) | 4.65 (0.76) |
| Facilitate the placement of the barrier | 0 (0.0) | 3 (1.6) | 10 (5.4) | 32 (17.2) | 141 (75.8) | 4.67 (0.65) |
| Inspect the condition of the stoma | 0 (0.0) | 1 (0.5) | 9 (4.8) | 32 (17.2) | 146 (77.7) | 4.72 (0.58) |
| Urostomy device (N = 58) | ||||||
| Comfortable using | 1 (1.7) | 1 (1.7) | 4 (6.9) | 18 (31.0) | 34 (58.6) | 4.43 (0.84) |
| Safe | 3 (5.2) | 1 (1.7) | 2 (3.4) | 24 (41.4) | 28 (48.3) | 4.26 (1.00) |
| Discrete (multichamber design) | 0 (0.0) | 0 (0.0) | 10 (17.5) | 13 (22.8) | 34 (59.6) | 4.42 (0.78) |
| Easy to use (drain valve or tap) | 1 (1.8) | 0 (0.0) | 3 (5.3) | 21 (36.8) | 32 (56.1) | 4.46 (0.76) |
| Easy to open and close (drain valve or tap) | 0 (0.0) | 0 (0.0) | 2 (3.6) | 22 (39.3) | 32 (57.1) | 4.54 (0.57) |
| Easy to empty (drain valve or tap) | 0 (0.0) | 0 (0.0) | 1 (1.8) | 19 (33.3) | 37 (64.9) | 4.63 (0.52) |
Table 5.
Adverse events and resolution.
| Adverse Event | Not Recovered Yet% (n) | Recovered % (n) | Total N = 278 % (n) |
|---|---|---|---|
| None | 92.4 (257) | ||
| Erythema | 12.5 (1) | 87.5 (7) | 2.7 (8) |
| Erosion | 100 (2) | 0.0 (0) | 0.7 (2) |
| Hypergranulation | 100 (2) | 0.0 (0) | 0.7 (2) |
| Necrotic tissue | 50.0 (1) | 50.0 (1) | 0.7 (2) |
| Leakage | 33.3 (1) | 66.6 (2) | 1.02 (3) |
| Prolapse | 100 (1) | 0.0 (0) | 0.34 (1) |
| Rod | 0.0 (0) | 100 (1) | 0.34 (1) |
| Irritation | 0.0 (0) | 100 (1) | 0.34 (1) |
| Pruritus | 0.0 (0) | 100 (1) | 0.34 (1) |
Table 6.
Evaluation of peristomal skin improvement in all patients according to the type of device and some characteristics.
Table 6.
Evaluation of peristomal skin improvement in all patients according to the type of device and some characteristics.
| Has Peristomal Skin Improved? (Scale 1 Nothing According to 5 Very Agree) (N = 294) | Value p | ||||||
|---|---|---|---|---|---|---|---|
| Nothing 1 n (%) | Little 2 n (%) | Indifferent 3 n (%) | Fairly 4 n (%) | Very 5 n (%) | Average (DE) | ||
| Type of device you currently use (opening) | 0.232 | ||||||
| Close | 10 (7.2) | 1 (0.7) | 15 (10.9) | 32 (23.2) | 80 (58.0) | 4.24 (1.15) | |
| Open | 5 (4.8) | 1 81.0) | 20 (19.2) | 40 (38.5) | 38 (36.5) | 4.01 (1.02) | |
| Drain valve | 3 (5.8) | 2 (3.8) | 8 (15.4) | 16 (30.8) | 23 (44.2) | 4.04 (1.14) | |
| Device currently used according to the type of sheet | 0.244 | ||||||
| Flat | 7 (4.8) | 1 (0.7) | 23 (15.8) | 39 (26.7) | 76 (52.1) | 4.21 (1.05) | |
| Soft Convexity | 10 (8.4) | 3 (2.5) | 16 (13.4) | 39 (32.8) | 51 (42.9) | 3.99 (1.20) | |
| Moderate Convexity | 1 (3.4) | 0 (0.0) | 4 (13.8) | 10 (34.5) | 14 (48.3) | 4.24 (0.95) | |
| Adhesive Border | 0.008 | ||||||
| No | 10 (5.7) | 2 (1.1) | 21 (11.9) | 42 (23.9) | 101 (57.4) | 4.26 (1.09) | |
| Yes | 8 (6.8) | 1 (1.7) | 22 (18.6) | 46 (39.0) | 40 (33.9) | 3.92 (1.09) | |
| Viewing option | 0.593 | ||||||
| No | 7 (5.3) | 2 (1.5) | 22 (16.8) | 42 (32.1) | 58 (44.3) | 4.08 (1.07) | |
| Yes | 11 (6.7) | 2 (1.2) | 21 (12.9) | 46 (28.2) | 83 (50.9) | 4.15 (1.31) | |
| Ostomized time | 0.236 | ||||||
| <1 week | 2 (7.4) | 0 (0.0) | 0 (0.0) | 7 (25.9) | 18 (66.7) | 4.44 (1.09) | |
| 1 week–1 month | 4 (5.9) | 1 (1.5) | 14 (20.6) | 27 (39.7) | 22 (32.4) | 3.91 (1.06) | |
| 1 month–3 months | 4 (5.9) | 1 (1.3) | 11 (14.3) | 24 (31.2) | 37 (48.1) | 4.16 (1.07) | |
| 3 months–6 months | 3 (5.5) | 1 (1.8) | 6 (10.9) | 15 (27.3) | 30 (54.5) | 4.24 (1.09) | |
| 6 months–12 months | 5 (7.5) | 1 (1.5) | 12 (17.9) | 15 (22.4) | 34 (50.7) | 4.07 (1.20) | |
Table 7.
Evaluation of the improvement of peristomal skin in patients with damaged and irritated skin according to the type of device and some characteristics.
Table 7.
Evaluation of the improvement of peristomal skin in patients with damaged and irritated skin according to the type of device and some characteristics.
| Has the Peristomal Skin Improved? (Scale 1 Nothing According to 5 Very Agree) (N = 104) | Value p | ||||||
|---|---|---|---|---|---|---|---|
| Nothing 1 n (%) | Little 2 n (%) | Indifferent 3 n (%) | Fairly 4 n (%) | Very 5 n (%) | Average (DE) | ||
| Type of device you currently use (opening) | 0.230 | ||||||
| Closed | 1 (2.8) | 0 (0.0) | 2 (5.6) | 1 (25.6) | 23 (53.5) | 4.44 (0.84) | |
| Drainable | 1 (2.0) | 1 (2.0) | 8 (15.7) | 18 (35.3) | 23 (45.2) | 4.11 (0.92) | |
| With valve | 0 (0.0) | 0 (0.0) | 1 (10.0) | 4 (40.0) | 5 (50.0) | 4.09 (1.19) | |
| Device currently used (per sheet) | 0.828 | ||||||
| Flat | 2 (4.7) | 1 (2.3) | 6 (14.0) | 11 (25.6) | 23 (53.5) | 4.21 (1.08) | |
| Soft convexity | 1 (2.0) | 1 (2.0) | 8 (15.7) | 18 (35.3) | 23 (45.1) | 4.20 (0.92) | |
| Moderate convexity | 0 (0.0) | 0 (0.0) | 1 (10.0) | 4 (40.0) | 5 (50.0) | 4.40 (0.70) | |
| Adhesive border | 0.011 | ||||||
| No | 1 (1.8) | 1 (1.8) | 4 (7.0) | 17 (29.8) | 34 (59.6) | 4.44 (0.85) | |
| Yes | 2 (4.3) | 1 (2.1) | 11 (23.4) | 16 (34.0) | 17 (36.2) | 3.96 (1.04) | |
| Viewing option | 0.437 | ||||||
| No | 1 (2.0) | 1 (2.0) | 10 (20.4) | 15 (30.6) | 22 (44.9) | 4.14 (0.96) | |
| Yes | 2 (3.6) | 1 (1.8) | 5 (9.1) | 18 (32.7) | 29 (52.7) | 4.29 (0.98) | |
| Ostomized time | 0.350 | ||||||
| <1 week | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (20.0) | 4 (80.0) | 4.80 (0.45) | |
| 1 week–1 month | 0 (0.0) | 0 (0.0) | 4 (25.0) | 7 (43.8) | 5 (31.3) | 4.07 (0.77) | |
| 1 month–3 months | 0 (0.0) | 1 (3.0) | 7 (21.2) | 10 (30.3) | 15 (45.5) | 4.18 (0.88) | |
| 3 motnhs–6 months | 1 (4.8) | 0 (0.0) | 0 (0.0) | 7 (33.3) | 13 (61.9) | 4.48 (0.93) | |
| 6 months–12 months | 2 (6.9) | 1 (3.4) | 4 (13.8) | 8 (27.6) | 14 (48.3) | 4.07 (1.20) | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Rivera García, S.; Espejo Lunar, E.-M.; Rodríguez-Almagro, J.; Louzao Méndez, S. Evaluation of Clinical Results regarding Peristomal Skin Health Associated with the Adjustment and Formulation of the New Moderma Flex One-Piece Ostomy Devices. J. Pers. Med. 2023, 13, 219. https://doi.org/10.3390/jpm13020219
AMA Style
Rivera García S, Espejo Lunar E-M, Rodríguez-Almagro J, Louzao Méndez S. Evaluation of Clinical Results regarding Peristomal Skin Health Associated with the Adjustment and Formulation of the New Moderma Flex One-Piece Ostomy Devices. Journal of Personalized Medicine. 2023; 13(2):219. https://doi.org/10.3390/jpm13020219
Chicago/Turabian StyleRivera García, Sebastian, Esperanza-Macarena Espejo Lunar, Julian Rodríguez-Almagro, and Silvia Louzao Méndez. 2023. "Evaluation of Clinical Results regarding Peristomal Skin Health Associated with the Adjustment and Formulation of the New Moderma Flex One-Piece Ostomy Devices" Journal of Personalized Medicine 13, no. 2: 219. https://doi.org/10.3390/jpm13020219
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
